ZAMRISTOBART
UNII 9YWY2J8E6E

Substance Identification & Data

This profile provides standardized clinical and technical data for Zamristobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9YWY2J8E6E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3036192-53-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9YWY2J8E6E

CAS Registry Number

3036192-53-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZAMRISTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179566

National Cancer Institute reference terminology for clinical and research data.

INN ID

13722

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zamristobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZAMRISTOBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN (1-446) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV3-6*01 (90.7%) -(IGHD) -IGHJ4*01 (94.1%)/HOMO SAPIENS IGHV4-59*01 (81.2%) -(IGHD) -IGHJ1*01 (90.9%), CDR-IMGT (9.7.12) (26-34.52-58.97-108)) (1-119) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10, 6-G4V3 CH2 E1.2 (CH1 (120-217), HINGE 1-12 S10>P (227) (218-229), CH2 L1.2>E (234), L92 (308) (230-339), CH3 (340-444), CHS (445-446)) (120-447)), (133-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (85.3%) -IGKJ2*01 (100%), CDR-IMGT (6.3.8) (27'-32'.50'-52'.89'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (227-PROLINE,234-GLUTAMIC ACID), ANTI-(HUMAN LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR B1) (HUMAN-MUS MUSCULUS MONOCLONAL SAR444881 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SAR444881 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS LILRB1 (LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR B1, ILT2, LIR-1, MIR7, CD85J)), MONOCLONAL ANTIBODY (ZAMRISTOBART)

ZAMRISTOBART [INN]